KASID
- Case Report A Case of Drug-induced Interstitial Lung Disease in a Patient withUlcerative Colitis Receiving Mesalamine
- Tae Hoon Lee, Suck-Ho Lee, Young-Sin Cho, Ji-Young Park, Jeong Hoon Park, Do Hyun Park, Il-Kwun Chung, Hong Soo Kim, Sang-Heum Park, Sun-Joo Kim, Mee-Hye Oh
- Intestinal Research 2007;5(2):192-195. Published online: December 30, 2007
Division of Gastroenterology, Department of Internal Medicine, Pathology, Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea
- 1,490 Views
- 20 Download
- 0 Crossref
- 0 Scopus
Abstract
Pulmonary involvement in ulcerative colitis is very rare and may present as a variety of disorders. Pulmonary disease in patients with inflammatory bowel disease may be due to lung involvement in the disease itself or to drugs used for treatment, such as sulfasalazine or mesalamine. The use of mesalamine was initially thought to be free of adverse effects. Recently, however, pulmonary diseases related to the use of mesalamine have been reported. In this report, we describe a patient with ulcerative colitis and mesalamine induced interstitial lung disease. (Intest Res 2007;5:192-195)
Cite
